We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
51 hedge funds and large institutions have $9.49M invested in Atossa Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
601% more call options, than puts
Call options by funds: $925K | Put options by funds: $132K
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
0.06% less ownership
Funds ownership: 1% → 0.94% (-0.06%)
9% less funds holding
Funds holding: 56 → 51 (-5)
40% less capital invested
Capital invested by funds: $15.8M → $9.49M (-$6.36M)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Holders
51
Holders Change
-5
Holders Change %
-8.93%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
11
Closed
12
Calls
$925K
Puts
$132K
Net Calls
+$793K
Net Calls Change
+$510K
Top Buyers
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$135K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$88.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$34.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$30.7K |
Top Sellers
| 1 |
E
Ergoteles
New York
|
-$264K |
| 2 |
D.E. Shaw & Co
New York
|
-$224K |
| 3 |
Renaissance Technologies
New York
|
-$192K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$159K |
| 5 |
Millennium Management
New York
|
-$81.3K |
